PSAMP
GVCI

P. Schoenfeld Asset Management (PSAM)’s Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares GVCI Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio GVCI Stock Details GVCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-76,202
Closed -$802K – 156
2023
Q1 		$802K Hold
76,202
– – 0.07% 85
2022
Q4 		$790K Sell
76,202
-518,798
-87% -$5.31M 0.07% 125
2022
Q3 		$6.03M Sell
595,000
-55,000
-8% -$555K 0.34% 52
2022
Q2 		$6.54M Hold
650,000
– – 0.38% 62
2022
Q1 		$6.49M Buy
+650,000
New +$6.45M 0.32% 76

P. Schoenfeld Asset Management (PSAM)'s GVCI Position: Q2 2023 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares (GVCI) in Q2 2023, closing a stake of 76,202 shares — an estimated $802K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in GVCI in Q1 2022 and held it in 5 quarters. The position peaked at $6.54M in Q2 2022. 0 funds tracked by Wall St. Rank hold GVCI as of Q2 2023.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 76,202 Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares shares in Q2 2023, an estimated $802K.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares position peaked at $6.54M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares as of Q2 2023.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2023, filed 11 Aug 2023.